Mainstay Capital Management’s Amgen AMGN Stock Holding History

Mainstay Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.77M	Buy	5,041 +98	+2%	+$34.9K	0.14%	47
2025 Q4	$1.62M	Sell	4,943 -511	-9%	-$162K	0.12%	52
2025 Q3	$1.54M	Sell	5,454 -4,865	-47%	-$1.41M	0.15%	53
2025 Q2	$2.88M	Buy	10,319 +5,339	+107%	+$1.51M	0.14%	58
2025 Q1	$1.55M	Hold	4,980	–	–	0.21%	45
2024 Q4	$1.3M	Buy	4,980 +171	+4%	+$50.7K	0.2%	47
2024 Q3	$1.55M	Buy	4,809 +1	+0%	+$327	0.26%	39
2024 Q2	$1.5M	Buy	4,808 +107	+2%	+$31.4K	0.26%	34
2024 Q1	$1.34M	Sell	4,701 -132	-3%	-$38.6K	0.25%	42
2023 Q4	$1.39M	Buy	4,833 +984	+26%	+$268K	0.26%	33
2023 Q3	$1.03M	Buy	+3,849	New	+$961K	0.22%	34
2018 Q4	–	Sell	-500	Closed	-$104K	–	102
2018 Q3	$104K	Sell	500 -100	-17%	-$19.7K	0.07%	142
2018 Q2	$111K	Buy	+600	New	+$106K	0.09%	110
2018 Q1	–	Sell	-5	Closed	-$1K	–	332
2017 Q4	$1K	Buy	+5	New	+$885	﹤0.01%	352

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Mainstay Capital Management's AMGN Position: Q1 2026 in Review

Mainstay Capital Management increased its Amgen (AMGN) stake by 2% in Q1 2026, buying an estimated $34.9K and bringing the position to 5,041 shares worth $1.77M. The position accounts for 0.14% of the portfolio, ranked #47.

Mainstay Capital Management first reported a position in AMGN in Q4 2017 and has held it in 14 quarters since. The position peaked at $2.88M in Q2 2025. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Mainstay Capital Management held 5,041 shares of Amgen worth $1.77M as of Q1 2026.
Mainstay Capital Management bought 98 Amgen shares in Q1 2026, an estimated $34.9K.
Amgen made up 0.14% of Mainstay Capital Management's portfolio in Q1 2026, its #47 holding.
Mainstay Capital Management first reported a position in Amgen in Q4 2017 and has held it in 14 quarters since.
Mainstay Capital Management's Amgen position peaked at $2.88M in Q2 2025.
3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Mainstay Capital Management's 13F filing for Q1 2026, filed 12 May 2026.